Collection probe and methods for the use thereof

Patent metadata

Field	Value
Publication number	US-12087566-B2
Application number	US-202318227417-A
Country	US
Kind code	B2
Filing date	Jul 28, 2023
Priority date	Sep 2, 2016
Publication date	Sep 10, 2024
Grant date	Sep 10, 2024

Abstract

Method and devices are provided for assessing tissue samples from a plurality of tissue sites in a subject using molecular analysis. In certain aspects, devices of the embodiments allow for the collection of liquid tissue samples and delivery of the samples for mass spectrometry analysis.

First claim

What is claimed is:

1. A method for assessing tissue samples from a subject, the method comprising:
(a) applying a fixed or discrete volume of a solvent to a tissue site in the subject using a probe, wherein the fixed or discrete volume of the solvent is applied using a pressure of less than 100 psig;
wherein the probe comprises a reservoir, a first conduit, a second conduit, and a third conduit, wherein:
the reservoir is in fluid communication with the first conduit, the second conduit, and the third conduit;
the first conduit is in fluid communication with a chamber comprising the solvent;
the second conduit is in fluid communication with a gas supply; and
the third conduit is in fluid communication with a mass spectrometer;

(b) collecting the applied solvent with the probe to obtain a liquid sample;
(c) transferring the liquid sample to the mass spectrometer via the third conduit and subjecting the liquid sample to mass spectrometry analysis, thereby obtaining a mass spectrometry profile; and
(d) characterizing the liquid sample based on the mass spectrometry profile;
wherein characterizing the liquid sample comprises determining whether the tissue site comprises:
normal lung, breast, ovarian, or thyroid cells;
benign lung, breast, ovarian, or thyroid cells; or
cancerous lung, breast, ovarian, or thyroid cells;
wherein the method produces no detectable physical damage to the tissue site.

2. The method of claim 1 , wherein the fixed or discrete volume of the solvent is not applied as a spray.

3. The method of claim 1 , wherein the fixed or discrete volume of the solvent is applied as a droplet.

4. The method of claim 1 , wherein the fixed or discrete volume of the solvent is applied using a pressure of less than 10 psig.

5. The method of claim 1 , wherein the fixed or discrete volume of the solvent is applied using a mechanical pump to move the solvent from the chamber through the first conduit to the reservoir.

6. The method of claim 1 , wherein collecting the applied solvent comprises applying a negative pressure to pull the sample from the reservoir into the third conduit and/or applying a gas pressure to push the sample from the reservoir into the third conduit.

7. The method of claim 1 , wherein the method does not involve application of ultrasonic or vibrational energy to the tissue.

8. The method of claim 1 , wherein the solvent comprises water, ethanol, or a combination thereof.

9. The method of claim 1 , wherein the fixed or discrete volume of the solvent is between about 0.1 and 100 μL.

10. The method of claim 1 , wherein the applied solvent is collected 0.1 to 30 seconds after being applied.

11. The method of claim 1 , further comprising collecting a plurality of liquid samples from a plurality of tissue sites.

12. The method of claim 11 , wherein the probe is washed between collection of each of the plurality of liquid samples; wherein the probe is disposable and is changed between collection of each of the plurality of liquid samples; or wherein the probe comprises a collection tip and the method further comprises ejecting the collection tip from the probe after each of the plurality of liquid samples are collected.

13. The method of claim 11 , wherein the plurality of tissue sites surrounds a section of tissue that has been surgically resected.

14. The method of claim 13 , wherein the resected tissue is a tumor.

15. The method of claim 1 , further defined as an intraoperative method.

16. The method of claim 1 , further comprising resecting tissue sites that are identified to include cancerous lung, breast, ovarian, or thyroid cells.

17. The method of claim 1 , wherein the liquid sample is obtained from the tissue site in vivo.

18. The method of claim 1 , wherein the liquid sample is obtained from the tissue site ex vivo.

19. The method of claim 1 , wherein, when tissue sites that are identified to include cancerous lung, breast, ovarian, or thyroid cells, the method further comprises administering an anti-cancer therapy to the subject.

Assignees

• Univ Texas

Inventors

• Eberlin Livia Schiavinato
• Milner Thomas
• Zhang Jialing
• Lin John
• Rector John
• Katta Nitesh
• Zahedivash Aydin

Classifications

• G01N33/575

  for cancer · CPC title

• H01J49/04

  Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components · CPC title

• G01N30/72

  Mass spectrometers {(mass spectrometers per se H01J49/00)} · CPC title

• G01N1/02

  Devices for withdrawing samples {(sampling of foundation soil E02D1/04; collecting or conveying radioactive samples G01T7/00, e.g. G01T7/02, G01T7/08)} · CPC title

• G01N33/6848 Primary

  Methods of protein analysis involving mass spectrometry · CPC title